CPT1A and lung cancer: Accordingly, etomoxir significantly decreased the oxygen consumption rate and the DNA repair capability of lung cancer cells resistant to radiotherapy and restored their radiosensitivity, suggesting CPT1A as a potential target for the treatment of radiation-resistant lung cancer [68].